Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/dd37021f-0cb5-48ed-8407-3337be669981/

SOM

SomnoMed Limited
Chart
0.60 AUD
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh

Factors computed — awaiting universe ranking

Fundamentals
Snapshot
Factors
Ranked
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
OS
Composite & Factor Heatmap
All factors at a glance
None
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 145 peers
P/B z-score
-0.36
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
BDX BCAL Diagnostics Limited
BGT Bio-Gene Technology Limited
BB1 BLINKLAB FPO [BB1]
AYA Artrya Limited
ACL Australian Clinical Labs Limited
ACR Acrux Limited
ACW Actinogen Medical Limited
ADR Adherium Limited
Factor Interactions
Volatility Expanding
60-day vol (104%) significantly exceeds 252-day (51%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
40.2% avg (4 factors)
Quality
F
25.6% avg (6 factors)
Momentum
F
21.3% avg (4 factors)
Risk
D
32.2% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
1.43
Price / Book
2.86
FCF Yield
-9.6%
Sales Yield (1/P·S)
0.7513
Shareholder Yield
Div + net buyback / mktcap
-27.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-26.7%
Return on Assets
-16.1%
Net Margin
-13.4%
Operating Margin
-9.1%
Gross Profit / Assets
Novy-Marx GPA
72.5%
Current Ratio
1.85
External Financing
Net issuance — lower=better
0.528
MomentumPrice trend strength over different horizons
6M Return
-24.1%
12M Return
-4.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-4.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.09
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
9.6%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
2
Dividend Yield
0.0%
Buyback Yield
-27.4%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity